“My people are destroyed for lack of knowledge: because thou hast rejected knowledge, I will also reject thee, that thou shalt be no priest to me: seeing thou hast forgotten the law of thy God, I will also forget thy children.” ~ Hosea 4:6

Rockefeller Medicine

Around 1900, the science world was getting excited about new “petrochemicals” and the ability to create a variety of new compounds from oil. Some of the first products derived from petrochemicals were plastics.

In 1908, modern medicine was established by the Rockefeller’s and dubbed “Allopathy”. The Rockefeller’s created the business of modern medicine which has always been about poisoning people, Eustice Mullen explains.

This is the Definition of Allopathic Medicine According to the NIH:

“A system in which medical doctors and other health care professionals (such as nurses, pharmacists, and therapists) treat symptoms and diseases using drugs, radiation, or surgery.”

The Rockefeller Institute for Medicine, founded in 1908, marked the advent of the re-creation of synthetic versions of natural cures. Prior to 1908, every place of healing in America, Europe and the world, used only ancient traditional natural medicinal cures. Every hospital was a “Homeopathic Hospital”. Most of these magnificent buildings were converted into mental health asylums where a system of torture and electric shock was established to “cure” mental illness.

“Everyone knows that the infamous Roe v. Wade opinion legalized abortion, but almost no one knows that legal abortion was a strategy by eugenicists, as early as 1939, to “genetically improve” the population by “reducing” it.”

In the book, “Rockefeller Medicine Men: Medicine and Capitalism in America”, authored by E. Richard Brown, he tells the hidden story of the financial, political, and institutional manipulations whereby a diverse and eclectic range of traditional healing modalities available to the North American public was summarily canceled and pared down to a singular style of medicine that would become the predominant medicine of the Western world and a major force in global medical culture during the 20th century. This was brought about largely by the collaboration of the American Medical Association, the philanthropies of Andrew Carnegie and John D. Rockefeller, and the development of a revolutionary curriculum by the Johns Hopkins School of Medicine. Brown documents the story of how a powerful professional elite gained virtual hegemony in the Western theatre of healing by effectively taking control of the ethos and practice of Western medicine. E. Richard Brown describes how, in 1905, the American Medical Association’s new Council on Medical Education funded by Carnegie and Rockefeller commenced serious activity. They employed the services of Abraham Flexner who proceeded to visit and “assess” every single medical school in the US and Canada. Within a short time of this development, medical schools all around the US began to collapse or consolidate. By 1910, 30 schools had merged, and 21 had closed their doors. Of the 166 medical schools operating in 1904, 133 had survived by 1910, and 104 by 1915. Fifteen years later, only 76 schools of medicine existed in the US and they all followed the same curriculum.

The 1910 Flexner Report laid the foundations of the modern medical system, dubbed “Rockefeller medicine” (Allopathy)

Since 1910, corporate interests have established near total control of the medical field, both though pharmacology and through their impact on medical education.

In 1935, vitamin C became the first vitamin to be artificially synthesized in Switzerland. Rockefeller saw a big opportunity with the possibility that vitamins and medications could be developed from petroleum. He saw the chance to control and monopolize multiple industries at once: petroleum, chemical and medical. Petrochemicals were ideal from a business perspective because they could be patented, owned and sold for high profits.

Today, thepetrochemicals in plastics are causing a slew of illnesses including neurodevelopmental disorders, diabetes, chronic respiratory disease, and cancer, which have increased between 28% and 150% between 1990 and 2019. Petrochemicals in microplastics are also rapidly reducing fertility in males in particular, and polluting our environment. Please also read more here, here, and here.

The first pharmaceutical drug was an arsenic named Salvarsan. That’s right, an ARSENIC POISON!

DEATH is an all-to-common side effect of pharmaceutical drugs which is only logical when you administer poisons internally.

The following research paper demonstrates the many deaths of people around the world, most of them children, who were fatally poisoned during the first mass medication experiments with Rockefeller’s Allopathic health. The paper is entitled, Toward Responsibility in International Health: Death following Treatment in Rockefeller Hookworm Campaigns, 1914–1934.

What is EDTA?

EDTA is synthesized on an industrial scale acid or poisons using 1, 2-diaminoethane (ethylene diamine), formaldehyde, water and sodium cyanide.

Ethylene diamine induced acute and subchronic toxicity in lab animals, also allergic hypersensitivity. The liver and kidneys are target organs of ethylenediamine, where they simply stop working.

Is C60 And EDTA Safe – A Clinical Review

Absorption of large amounts of formaldehyde via any route can cause severe systemic toxicity, leading to metabolic acidosis, tissue and organ damage, and coma, according to the CDC.

Exposure to sodium cyanide can be rapidly fatal. It has whole-body (systemic) effects, particularly affecting those organ systems most sensitive to low oxygen levels: the central nervous system (brain), the cardiovascular system (heart and blood vessels), and the pulmonary system (lungs), according to the CDC.

EDTA is an industrial poison!

The textile industry required a chelating agent to remove calcium during textile processing and this led to the synthesis of polyamino-carboxylic acids, one of which was EDTA.

A patent was filed for EDTA in Germany in 1935, for industrial chemical use. EDTA is a synthetic acid effectively used to clean boiler rooms in nuclear power plants. In 1945, Franz Munz obtained a US EDTA patent in 1945. In 1947, EDTA was approved by the US Food and Drug Administration (FDA) as a food additive in “low doses” because it’s a forever chemical and a preservative.

There are two different types of EDTA approved by the U.S. FDA. In 1953, Edetate calcium disodium also known as Calcium EDTA (marketed under the trade name Calcium Disodium Versenate registered) was approved for the treatment of lead poisoning. Three years later, in 1956, a related EDTA compound, Edetate disodium, was also approved for clinical use. This compound, also known as Disodium EDTA, has been marketed under the trade names Disotate (registered) and Endrate (registered). The essential difference between these two compounds is that Calcium EDTA’s structure has an incorporated Ca super(2+) moiety while Disodium EDTA does not. The use of the latter compound, Disodium EDTA, has been associated with life-threatening and fatal hypocalcemia.

EDTA RESEARCH TRIAL DEATHS

An EDTA trial (Sloth-Nielsen et al., 1981) on the possible antiatherogenic effect of EDTA with 6 patients, showed clinical signs of potentially lethal hypocalcemia from abnormally low calcium levels caused by EDTA.

Another EDTA chelation human trial in 2003-2005 resulted in DEATHS due to hypocalcemia.

A 2006 EDTA chelation trial also resulted in DEATHS due to hypocalcemia.

There were several DEATHS reported from cardiac arrest due to lethal hypocalcemia in EDTA trials in 2006 and 2008 and (Brown, Willis, Omalu, & Leiker, 2006; Baxter & Krenzelok, 2008), from calcium deficiency inducing alterations in the brain, and osteoporosis, which causes the bones to become brittle.

In 2008, a clinical trial with EDTA chelation on autistic children also proved fatal, resulting in DEATHS of children.

A 2007 EDTA chelation studyproved KIDNEY FAILURE in humans.

Decades of clinical studies demonstrate that EDTA treatment is associated with severe, life-threatening adverse effects, as Science Direct explained in 2016.

“It should be emphasized that EDTA treatment is associated with severe, life-threatening adverse effects.

EDTA for Cardiovascular Disease DEBUNKED

Many allopathic specialists tried to popularize the use of EDTA for chelation, to no avail. In the 1980s, Richard Casdorph, a practicing cardiologist, claimed improvements in ejection fractions of the heart and in cerebral blood flow with EDTA chelation therapy in several articles.

McDonagh, Rudolph, and Cheraskin published about 30 articles documenting various positive effects of EDTA chelation. This group wrote articles showing no problems with kidney function in patients treated with EDTA according to the published protocol.

At the same time, conventional cardiologists wrote several editorials against EDTA chelation.

So the American Medical Association called for studies to see if chelation worked. The American Board of Chelation Therapy in 1983 was formed to certify doctors who give the therapy. It was later called the American Board of Clinical Metal Toxicology. ACAM also certified doctors who took its workshop on chelation therapy and passed its written and oral examinations.

The Great Lakes College of Clinical Medicine, later called the International College of Integrative Medicine (ICIM), was formed in 1983 to teach and do research on chelation and other integrative therapies. After complex negotiations, in the late 1980’s Walter Reed Army Hospital agreed to do a randomized clinical trial on EDTA chelation therapy, but part way through the study it was suddenly discontinued for unknown reasons.

However, in a paper by Seely, Wu, and Mills, (2005), a systematic review of published articles in this field was undertaken. The authors concluded that the best current available evidence did not support the therapeutic use of EDTA chelation therapy in the treatment of cardiovascular disease. Similar results have been reported in review papers by Shrihari, Roy, Prabhakaran, and Reddy (2006) and Crisponi et al. (2015).

While a 2002 EDTA large randomized clinical trial “showed benefit”, smaller studies were inconsistent.

In the 1990s, the Federal Trade Commission filed a complaint against ACAM for making a claim in a brochure that chelation was effective for vascular disease. ACAM submitted almost 100 articles in support of the claim, but the FTC insisted that a large randomized trial was required to make that claim. ACAM finally gave up after spending a million dollars in legal fees and signed a consent order saying they would not make such a claim anymore, based on the evidence at that time.

In conclusion, our study shows that in a population of stable, largely asymptomatic coronary artery disease patients with prior myocardial infarction, use of EDTA chelation therapy did not produce a measurable change in health-related quality of life over 2 years of follow-up.

A slew of other adverse events such as lacrimation, nasal congestion, mucocutaneous lesions, glycosuria, hypotension, and ECG abnormalities (DISEASE OF THE HEART AND LUNGS) have also been reported as well as allergic reactions (Wax, 2013) to EDTA.

Prolonged treatment with calcium EDTA gives rise to depletion of magnesium and trace-metal depletion, the most marked being due to the excretion of zinc. Zinc depletion destroys your cells’ ability to absorb nutrients and leads to diabetes.

A 2015 study entitled, Quality of Life Outcomes with a Disodium EDTA Chelation Regimen for Coronary Disease: Results from the TACT Randomized Trial concluded with this statement:

“In conclusion, our study shows that in a population of stable, largely asymptomatic coronary artery disease patients with prior myocardial infarction, use of EDTA chelation therapy did not produce a measurable change in health-related quality of life over 2 years of follow-up.”

Severe kidney damage from EDTA chelation therapy was reported in a (Nissel 1986) trial. In a very short period of time, EDTA causes kidneys to shut down in complete failure.

A study from 2015 suggests EDTA chelation for myocardial infarction with “modest” benefits to cardio health.

However, I would suggest that the moderate benefits of this study were due to the high doses of vitamin C administered.

A 2017 study on EDTA chelation for atherosclerosis and Miocardial Infraction concluded:

“Unsubstantiated claims of chelation therapy as an effective treatment of atherosclerosis should be avoided and patients made aware of the inadequate evidence for efficacy and potential adverse effects, especially the harm that can occur if used as a substitute for proven therapies.”

In a 2018 EDTA trial it was concluded:

“These results… are not sufficient to support the routine use of chelation therapy for treatment of patients who have had an MI (Miocardial Infraction)”.

A study from 2023 entitled, Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results proved a flop with two participants discontinuing their trial participation.

EDTA for Lead Poisoning DEBUNKED

EDTA has also been touted as a treatment for lead poisoning. Because of its adverse effects, calcium EDTA was replaced by DMSA in the treatment of lead poisoning (Aposhian et al., 1995) in 1995. CaEDTA has also been used for the treatment of cases with manganese toxicity, but the result was neurotoxic symptoms resembling PARKINSONISM (Andersen, 1999).

A 2004 trial showed that EDTA actually REDISTRIBUTES LEAD TO THE BRAIN after acute or chronic lead exposure (Andersen, 2004).

Another trial proved adverse effects in 5 patients receiving EDTA at an outpatient chelation clinic in 2002, and all patients experienced gastrointestinal and musculoskeletal symptoms.

Oral exposure to EDTA (2002) had produced adverse reproductive and developmental effects in animals. EDTA did not make it past the animal or human trials, so why are medical doctors using it in humans?

A 2002 EDTA trial was performed on humans as a test for “chelation” therapy by a chelation clinic, demonstrating adverse events in 5 out of 5 patients.

Additionally, EDTA is a persistent organic pollutant (POP). In that case, each intake would only be partially excreted, while the remaining chemicals build up in the body and produce cell death. And long-term exposure to calcium disodium EDTA creates toxicity and kidney damage.

EDTA is not an approved pharmaceutical drug. It was Covid Emergency approved by the FDA under an Emergency Use Authorization (EUA), just like the modified RNA (modRNA) Covid-19 vaccine nanotechnology.

The National Center for Complementary and Integrative Health (.gov) makes it clear that the use of EDTA chelation for heart disease has not been approved by the FDA.

Today, there are medical doctors and health practitioners who have been touting EDTA as an “antioxidant” when it is not. In fact, it’s an acidic poison and an oxidant.

A licensed medical doctor should know whether EDTA is an oxidant poison or an antioxidant. Not knowing this and

inducing a health risk to the patient

is not an acceptable excuse.

EDTA is an oxidant when used internally. The studies that refer to EDTA as an “antioxidant” are in vitro lab studies, not in vivo (inside the body).

EDTA is used to preserve cell specimens for chemistry lab work because it prevents blood coagulation and oxidation of cells in a petri dish where it’s used for diagnostic purposes. This is the kind of “antioxidant” the studies are referring to. But when you infuse EDTA synthetic acid into the human body, it acts as an oxidant poison.

EDTA, will not decoagulate the blood in vivo (inside the body). But I can see how people who do not read peer-reviewed literature could be deceived and manipulated by those using EDTA synethic acid.

For example, a study entitled, “Comparative study of the antioxidant capability of EDTA and Irganox”. EDTA is a preservative used in laboratories to preserve cells for scientific lab research. EDTA prevents the oxidation of cells in a petri dish. Oxygen causes cells to deteriorate, but labs need them to last longer for research purposes. When used inside the human body (in vivo), it’s a different story. Then, EDTA acts as an oxidant acidic poison, not an antioxidant. So this has a very different meaning.

One of the well documented and widely known adverse events from EDTA “chelation” is DEATH, according to Mount Sinai.

Other serious side effects of EDTA that have been reported include low blood sugar, diminished calcium levels, headache, nausea, dangerously low blood pressure, kidney failure, organ damage, irregular heartbeat, seizures, or even death.

EDTA is NOT a Detox Agent!

Again, EDTA is an oxidant that degrades cells whereas genuine antioxidants repair cells.

Saul Green, Ph.D., and Wallace I. Sampson, M.D. wrote in great detail about the Implausibility of EDTA Chelation Therapy, stating:

“EDTA chelation effectiveness is implausible; (2) the preponderance of evidence shows ineffectiveness; and (3) EDTA augments oxidative reactions involving iron instead of inhibiting them, resulting in increased likelihood of production of oxygen free radicals rather than neutralization of them, as claimed.”

https://rumble.com/v5576u8-transfection-democide-and-the-internet-of-bodies-dr.-robert-young.html

EDTA is a Precurser to Cellular Transfection

The Rockefeller Institue of Medicine has done clinical research on EDTA. One particular study entitled, Studies of Cell Deformity from 1967, shows that cells will degrade from EDTA exposure, which also induces “deformation” on their surfaces. The trial demonstrated that EDTA stops cellular synthesis of calcium. They learned that calcium is bound to anionic sites at the cell periphery, some of which are located at the cellular electrokinetic surface.

Due to Rockefeller’s research, EDTA is now used in electrophoresis which is a laboratory technique used to separate DNA, RNA or protein molecules based on their size and electrical charge. An electric current is used to move the molecules through a gel or other matrix, according to the National Human Genome Research Institute.

In agarose gel electrophoresis, EDTA is added for chelating the magnesium ions which are cofactors for DNA nucleases.

Hence, activity of DNA nucleases that may be present is inhibited, and “DNA is protected from degrading”. This is why EDTA is an effective transfection agent because it dissolves parts of your DNA, preserving cells for lab research in vitro.

Gel electrophoresis using EDTA is routinely used for detection and size analysis of proteins and nucleic acid.

DMSO is used with EDTA in this process. This destruction of cells makes transfection (gene editing) of cells easier using CRISPR-Cas9 which splices and dices the genome in vivo, as this study explains entitled, “Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2”.

EDTA was found to be genotoxic in laboratory animals. A study from 1983 demonstrates that EDTA induces gene mutations and chromosomal breakage, meaning that genetic mutations will be passed on your offspring, affecting generations to come, according to this Genetic Toxicology of EDTA study from 1983.

Calcium chelate of EDTA (CaEDTA) “chelation” has shown teratogenic effects (Catsch & Harmuth-Hoene, 1976), which are central nervous system depression and peripheral neuropathy. EDTA produced abnormalities in pups of rats removed by cesarian section on day 21 of the study. Increases in several abnormalities (cleft palate, adactyly or syndactyly, abnormal rib or abnormal vertebrae) were observed with increased doses of CaEDTA.

EDTA improves transfection of embryonic stem cells lines (hESC) in cells, according to the NIH.

According to a peer reviewed paper from the NIH, EDTA is a precursor to cellular transfection.

“We found that chemically abrading the differentiated CACO-2 human intestinal epithelial cell layer by a trypsin and EDTA pretreatment (before the use of detergent-like transfection reagents) dramatically improved transfection efficiency in this polar, differentiated model. Although this treatment did improve the transfection efficiency, it also induced leakiness in the epithelial barrier by both opening tight junctional complexes and by creating holes in the cell layer because of low-level cell death and detachment. Thus, this approach to enhance the transfection efficiency of polar, differentiated cells will be useful for assessment of the effect of the transfected/expressed protein on (re)formation of an epithelial barrier…”

An NIH study entitled, “Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a” reveals that EDTA enables rapid binding to DNA during gene editing (transfection).

Graphene oxide/Lauric acid nanoparticles are modified using EDTA. Lauric acid nanoparticles is suggested as a “prospective drug carrier” for oral nanoparticle-mediated sustained drug delivery (timed release technology) used for the removal of Pb(II) ions (lead). However, studies show there are cytotoxic results.

Another study entitled, “Improved genome editing by an engineered CRISPR-Cas12a” demonstrates how EDTA improves transfection and modification of the human genome.

Once graphene is reduced to graphene oxide, due to its small particulate size, you can no longer identify it using a dark-field microscope.

There are several doctors using dark-field microscopy at low magnigication and without using scanning, transmission or bright field microscopy confirmed by directed energy x-ray spectroscopy, which are the only instruments that can be used to measure the presence of GON and Quantum Nano Dots.

What is Happening With EDTA Infusions?

Some doctors are creating a metal-EDTA complex that stabilizes and strengthens the graphene-based nanotech weapon system and enables it to spread more readily throughout the body, for human transfection. They use “light and sound healing techniques” to activate the delayed release technology before administering EDTA infusions.

EDTA is an acidic poison that dissolves DNA. It’s used to prime the cells’ DNA for transfection. EDTA disrupts the surface of skin cells so that other forever chemicals, micro plastics and graphene oxide can penetrate more easily and CRISPR-Cas9 gene editing technology can work more efficiently.

The NIH describes EDTA’s enhanced cellular transfection:

“Flow cytometric analysis using an enhanced green fluorescent protein vector showed a significantly increased transfection efficiency of EDTA method compared to standard enzyme method. In addition, the EDTA approach maintained stable cell viability and recovery rate of hESCs after transfection.”

Another study published in Research Gate, confirms that EDTA increases cellular transfection, along with using hydroxychloroquine.

Graphene Oxide Quantum Dots (GOQD-HA) nanocomposite use EDTA for tissue-specific delivery of Metformin, an anti-diabetic drug otherwise known as insulin.

[Scanning & Transmission Electron Microscopy Reveals the Nano Hexagonal Multi-demensional Construct of

MasterPeace™ Zeolite Z™ – Copyright Dr. Robert O. Young & Hikari Omni Publishing, 2024]

To test the efficacy of MasterPeace™ Zeolite Z™ in removing heavy metals[6], forever chemicals[7], micro plastics[8], micro and nano graphene and aluminum[9][10] and other toxic compounds from the body cells and fluids, a study was conducted involving three test subjects, two adult females and one adult male. The objective was to determine the safety and efficiency of MasterPeace™ Zeolite Z™ in detoxification of these micro and nano toxins.

The study employed an intracellular fluids toxicity test of the blood with baseline results collected before starting the regimen, followed by tests at 35 days and 90 days. The test subjects took the MasterPeace™ Zeolite Z™ natural product daily at a specified dosage of 5 drops under the tongue, twice a day.

The intracellular fluid toxicity test[11] targeted highly toxic compounds and elements that were believed to be present in the body but had not been previously tested. This study aimed to evaluate the baseline of these toxic compounds and how effectively MasterPeace™ Zeolite Z™ could chelate and remove these toxic compounds from the body. The specific toxic compounds and elements tested are listed below.

The sea plasma in MasterPeace™ Zeolite Z ™ is known for its detoxification and remineralization properties [1], enhancing the products’ overall effectiveness. This

ingredient also supports the removal of toxins while replenishing essential minerals in the body.[4]

The study aimed to test the combined effects of both nano-sized clinoptilolite zeolite and sea plasma in promoting overall detoxification and health. The findings from these tests provide insights into the comprehensive detoxification

capabilities of MasterPeace™ Zeolite Z™, measuring its impact on reducing the toxic burden in human blood.[12][13][14]

Introduction

Background: The Human Consciousness Support™ Company and their product MasterPeace™ ZeoliteZ™, was developed within the last two years, as an all-natural detoxification product potentially capable of removing toxic substances from the body.

MasterPeace™ Zeolite Z™ has been refined with the input of numerous scientific minds, focusing not only on the optimization of the nano-sized zeolite but also on the innovative combination of clinoptilolite zeolite with inland sea plasma at a pH of 8.3 and a oxidative reduction   potential (ORP) value of -90mV.[15] This unique formulation, known as MasterPeace™ Zeolite Z™, is designed to operate at a pH of 8.3 and -90mV, which enhances its efficacy. According to Human Consciousness Support Company™ literature [5], MasterPeace™ Zeolite Z™ is a synergistic blend of natural ingredients which is claimed to be effective natural product or nutraceutical available for detoxification, targeting and removing a wide range of toxic nano and micro compounds from the human body.[5]

Rationale: To address a critical gap in our understanding of the presence and detoxification of specific toxic micro and nano toxic compounds in the human body. In today’s world, individuals are constantly exposed to myriads of toxic micro and nano toxic substances, many of which are known to be cytotoxic, genotoxic and bio magnetic toxic to the human blood, cells and tissues.[1]

However, there is limited accessibility and availability of testing for these compounds in many countries, making it difficult for them to obtain baseline measurements of these harmful and toxic agents in their bodies.

By testing for specific toxic compounds in the blood of three subjects, this study aims to fill a crucial knowledge gap.

Establishing baseline levels of these toxic substances is essential for understanding their prevalence and potential impact on health. Additionally, evaluating the efficacy of the MasterPeace™ Zeolite Z™, which combines nano-sized colloidal clinoptilolite zeolite with sea plasma (known as Zeolite Z™, in removing known micro and nano toxins is equally important. The findings from this study provides valuable insights into the safety and effectiveness of this detoxification approach, potentially offering a viable solution for individuals seeking to reduce their toxic burden and improve their overall health.

Objectives: The purpose of this study was to obtain information based on blood.[11] We wanted to evaluate the toxic burden on the human body. We chose initially five data points being graphene oxide (2D Nano)[16] , polyethylene (PE)[17], polypropylene (PP)[18], perfluoro octane sulfonate-acid (PFOS)[19][20][21][22] and perfluorooctanoic-acid (PFOA)[19][20][21][22]. At the 35-day mark we included five more compounds which were aluminum[23], glyphosate[24], iron[25], lindane[26] and phosgene[27].

Methodology

Study Design: This pilot study employed a pre-test, post-test design to evaluate the efficacy of the intervention.

Setting: The pilot study was conducted in a real-world home environment, were the participants took the product for 90days. The controlled aspect of the study involved the blood collection, by a phlebotomist from the participating subjects at designated intervals.

Participants: Participants were selected to include both COVID-19 vaccinated[28] and non-vaccinated individuals of European descent. There were three test subjects, female aged 57, male aged 57, and female aged 60, respectively.

Intervention: The product being tested for its safety and efficacy in chelating and removing toxic foreignmicro and nano toxins in the body cells and fluids was MasterPeace™ Zeolite Z™ manufactured and distributed by Human Support Consciousness Support™ company.[5] Following the baseline test, participants took a dosage of five drops twice daily, administered under the tongue sublingually. The duration of the study was 90 days.

Laboratory Test: iEC – Cellular Toxin Examination. Inadequate detoxification or increased exposure to toxic substances can cause them to accumulate in the body fluids and body cells.

These toxins can impair cellular processes such as energy supply through the respiratory chain in the mitochondria or attach to DNA and form a DNA adduct.[29] With the iEC examination (iEC for intracellular electrical capacity), the intracellular amount of toxins in the lymphocytes canbe determined and possible exposure can be detected at an early stage.[12]

Control Group: There was no control group in this initial pilot study.

Outcome Measures: The primary outcome measure was the intracellular toxicity test of the blood.[11] We started the study by testing each subject for 5 substances and their tolerance levels, including graphene oxide (2D Nano)[16] , polyethylene (PE)[17], polypropylene (PP)[18], perfluorooctane sulfonate-acid (PFOS)[19][20][21][22] and perfluorooctanoic-acid (PFOA)[19][20][21][22], as our baseline before intervention as seen in Chart 1 below:

Chart 1

Data Collection: An outsourced phlebotomist was employed to take venous blood samples from each test subject, with 3×4 ml vials collected at baseline, 35 days, and

90 days.

Statistical Analysis: Blood samples of participating subjects were measured for toxic compounds at nanomoles per liter (nmol/L) with the following reference ranges:

– Tolerable: 0 to 14,999 nmol/L

– Borderline: 15,000 to 29,999 nmol/L

– High: 30,000 to 44,999 nmol/L

– Very High: 45,000 to 65,000 nmol/L

Four separate sensors are used in the measuring equipment at the third-party lab to obtain four values.[11] Measurements included Arithmetic mean of values (AM) 1 to 4 and Mean Absolute Deviation (MAD).[11]

Results

Participating Subject Flow: All three subjects enrolled in and successfully completed the study.

Baseline Characteristics: Each subject voluntarily agreed to take part in the study and confirmed adherence to the study protocol. To prevent any potential bias orinfluence on the study outcomes, participants were not informed of their individual results until the conclusion of the study. This approach was intended to avoid any anxiety or actions, such as taking additional detox products, that might arise from learning about high toxic levels found in the blood.

Participating subjects were instructed to maintain their usual diet and lifestyle throughout the study. They were explicitly advised not to engage in any additional supplement, diet, or lifestyle detox protocols during the study period.

Primary Outcomes: The baseline blood tests revealed that all test subjects had predominantly high and very high levels of toxic substances in their blood as shown in Chart 1 and Chart 2 above.

As the study progressed, the 35-day blood tests indicated a reduction in these levels, with most falling into the borderline and tolerable ranges as seen in the baseline, 35 days and 90-day testing for all 10 toxic substances that reduced to the tolerable and borderline ranges of <300 shown in the following charts 3, 4 and 5 below.

By the 90-day mark, the blood tests showed that all subjects’ toxin levels had further decreased, with all measurements falling within the borderline and tolerable ranges.

Chart 3

CR Baseline, 35 days and 90 days.